Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer. [electronic resource]
Producer: 20190319Description: e89-e95 p. digitalISSN:- 1938-0666
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- therapeutic use
- Epothilones -- therapeutic use
- Fatigue -- chemically induced
- Female
- Humans
- Infusions, Intravenous
- Kaplan-Meier Estimate
- Middle Aged
- Peripheral Nervous System Diseases -- chemically induced
- Progression-Free Survival
- Prospective Studies
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Response Evaluation Criteria in Solid Tumors
- Triple Negative Breast Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.